Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

The original published version of this article contained errors in the RESULTS section and Fig. 2D. Before correction Meta-analysis from these studies showed administration of LDN was associated with a higher number of patients who experienced at least 30% improvement in pain when compared to a placebo (OR: 3.32, 95% CI: 1.59, 6.92, P = 0.001, I2 = 0%, random-effect model). After correction Meta-analysis from these studies showed administration of LDN was associated with a higher number of patients who experienced at least 30% improvement in pain when compared to a placebo (OR: 2.47, 95% CI: 1.10, 5.54, P = 0.03, I2 = 7%, random-effect model).